Assistant Professor Andrew Monteith's lab in the Department of Microbiology is documenting how key immune cells detect ...

In a new study, researchers explored experiences, perceptions, and health effects of a newly developed healthy lifestyle ...

A minimum of 3 years of sustained clinical remission may protect against an increase in disease activity and the development ...

Patients with cutaneous lupus erythematosus who used hydroxychloroquine had a significantly reduced risk of developing systemic lupus erythematosus.

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

Members of the Systemic Lupus Erythematosus International Collaborating Clinics (SLICC) group along with experienced ...

Received Clearance from the U.S. Food and Drug Administration (FDA) for Clinical Trials of Budoprutug in Primary Membranous Nephropathy (pMN), ...

Research shows multiple factors drive CKD risk in lupus nephritis, including nephritic flares, baseline hypertension, renal ...